As of 3:57pm ET
| +0.89 / +0.65%|
The 26 analysts offering 12-month price forecasts for Bayer have a median target of 131.81, with a high estimate of 167.93 and a low estimate of 109.98. The median estimate represents a -4.20% decrease from the last price of 137.59.
The current consensus among 28 polled investment analysts is to Buy stock in Bayer. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.